Full Text
AC3 - DISCORDANT DESIGNATIONS OF BREAKTHROUGH DRUG INNOVATION- FRANCE VERSUS THE UNITED STATES

Abstract

Authors

E. Sam B.J. Adamson L.P. Garrison

Back to Volume 21, Supplemental S3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×